<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-id journal-id-type="hwp">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26604147</article-id>
<article-id pub-id-type="pmc">4690499</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddv464</article-id>
<article-id pub-id-type="publisher-id">ddv464</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Altered microtubule dynamics and vesicular transport in mouse and human MeCP2-deficient astrocytes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Delépine</surname>
<given-names>Chloé</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meziane</surname>
<given-names>Hamid</given-names>
</name>
<xref ref-type="aff" rid="af4">4</xref>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="aff" rid="af6">6</xref>
<xref ref-type="aff" rid="af7">7</xref>
<xref ref-type="aff" rid="af8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nectoux</surname>
<given-names>Juliette</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="aff" rid="af9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Opitz</surname>
<given-names>Matthieu</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Amos B.</given-names>
</name>
<xref ref-type="aff" rid="af10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ballatore</surname>
<given-names>Carlo</given-names>
</name>
<xref ref-type="aff" rid="af10">10</xref>
<xref ref-type="aff" rid="af11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saillour</surname>
<given-names>Yoann</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bennaceur-Griscelli</surname>
<given-names>Annelise</given-names>
</name>
<xref ref-type="aff" rid="af12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Qiang</given-names>
</name>
<xref ref-type="aff" rid="af13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Emily Cunningham</given-names>
</name>
<xref ref-type="aff" rid="af13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dahan</surname>
<given-names>Maxime</given-names>
</name>
<xref ref-type="aff" rid="af14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duboin</surname>
<given-names>Aurélien</given-names>
</name>
<xref ref-type="aff" rid="af14">14</xref>
<xref ref-type="aff" rid="af15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Billuart</surname>
<given-names>Pierre</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Herault</surname>
<given-names>Yann</given-names>
</name>
<xref ref-type="aff" rid="af4">4</xref>
<xref ref-type="aff" rid="af5">5</xref>
<xref ref-type="aff" rid="af6">6</xref>
<xref ref-type="aff" rid="af7">7</xref>
<xref ref-type="aff" rid="af8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bienvenu</surname>
<given-names>Thierry</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="aff" rid="af9">9</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="af1"><label>1</label><institution>Inserm, U1016, Institut Cochin</institution>, <addr-line>Paris</addr-line>, <country>France</country>,</aff>
<aff id="af2"><label>2</label><institution>Cnrs, UMR8104</institution>, <addr-line>Paris</addr-line>, <country>France</country>,</aff>
<aff id="af3"><label>3</label><institution>Université Paris Descartes, Sorbonne Paris Cité</institution>, <addr-line>Paris</addr-line>, <country>France</country>,</aff>
<aff id="af4"><label>4</label><institution>Institut Clinique de la Souris (ICS), PHENOMIN, GIE CERBM</institution>, <addr-line>Illkirch</addr-line>, <country>France</country>,</aff>
<aff id="af5"><label>5</label><institution>Institut de Génétique et de Biologie Moléculaire et Cellulaire</institution>, <addr-line>Illkirch</addr-line>, <country>France</country>,</aff>
<aff id="af6"><label>6</label><institution>Centre National de la Recherche Scientifique, UMR7104</institution>, <addr-line>Illkirch</addr-line>, <country>France</country>,</aff>
<aff id="af7"><label>7</label><institution>Institut National de la Santé et de la Recherche Médicale, U964</institution>, <addr-line>Illkirch</addr-line>, <country>France</country>,</aff>
<aff id="af8"><label>8</label><institution>Université de Strasbourg</institution>, <addr-line>Illkirch</addr-line>, <country>France</country>,</aff>
<aff id="af9"><label>9</label><institution>Laboratoire de Biologie et Génétique Moléculaires, HUPC, Hôpital Cochin</institution>, <addr-line>Paris</addr-line>, <country>France</country>,</aff>
<aff id="af10"><label>10</label><addr-line>Department of Chemistry, University of Pennsylvania, Philadelphia, PA, USA</addr-line>,</aff>
<aff id="af11"><label>11</label><addr-line>Center of Neurodegenerative Disease Research</addr-line>, <institution>University of Pennsylvania</institution>, <addr-line>Philadelphia, PA</addr-line>, <country>USA</country>,</aff>
<aff id="af12"><label>12</label><institution>ESTeam Paris-Sud, Université Paris-Sud 11, Inserm U935</institution>, <addr-line>Villejuif</addr-line>, <country>France</country>,</aff>
<aff id="af13"><label>13</label><addr-line>Department of Genetics and Neurology</addr-line>, <institution>University of Wisconsin-Madison</institution>, <addr-line>Madison, WI</addr-line>, <country>USA</country>,</aff>
<aff id="af14"><label>14</label><institution>Laboratoire Physico-Chimie Curie, Institut Curie, CNRS UMR168, UPMC</institution>, <addr-line>Paris</addr-line>, <country>France</country> and</aff>
<aff id="af15"><label>15</label><institution>ALVEOLE</institution>, <addr-line>Paris</addr-line>, <country>France</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>To whom correspondence should be addressed at: Université Paris Descartes, Institut Cochin, 24 rue du Faubourg St Jacques, 75014 Paris, France. Tel: +33 1 44 41 24 79; Fax: +33 58 41 15 80; Email: <email>thierry.bienvenu@inserm.fr</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>25</volume>
<issue>1</issue>
<fpage>146</fpage>
<lpage>157</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>11</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="ddv464.pdf"></self-uri>
<abstract>
<p>Rett syndrome (RTT) is a rare X-linked neurodevelopmental disorder, characterized by normal post-natal development followed by a sudden deceleration in brain growth with progressive loss of acquired motor and language skills, stereotypic hand movements and severe cognitive impairment. Mutations in the methyl-CpG-binding protein 2 (<italic>MECP2</italic>) cause more than 95% of classic cases. Recently, it has been shown that the loss of Mecp2 from glia negatively influences neurons in a non-cell-autonomous fashion, and that in <italic>Mecp2</italic>-null mice, re-expression of Mecp2 preferentially in astrocytes significantly improved locomotion and anxiety levels, restored respiratory abnormalities to a normal pattern and greatly prolonged lifespan compared with globally null mice. We now report that microtubule (MT)-dependent vesicle transport is altered in <italic>Mecp2</italic>-deficient astrocytes from newborn Mecp2-deficient mice compared with control wild-type littermates. Similar observation has been made in human <italic>MECP2</italic> p.Arg294* iPSC-derived astrocytes. Importantly, administration of Epothilone D, a brain-penetrant MT-stabilizing natural product, was found to restore MT dynamics in <italic>Mecp2</italic>-deficient astrocytes and in <italic>MECP2</italic> p.Arg294* iPSC-derived astrocytes <italic>in vitro</italic>. Finally, we report that relatively low weekly doses of Epothilone D also partially reversed the impaired exploratory behavior in <italic>Mecp2<sup>308/y</sup></italic> male mice. These findings represent a first step toward the validation of an innovative treatment for RTT.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>Fondation Jerome Lejeune, Labex ‘Who I am?’, the Université Paris Descartes and the Association Française du Syndrome de Rett</funding-source>
<award-id>AFSR, 2005-01, RAK15121KKA</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>‘Genetic and Epigenetic Networks in Cognitive Dysfunction’</funding-source>
</award-group>
<award-group id="funding-3">
<funding-source>(GENCODYS) consortium</funding-source>
<award-id>FP7-COLLABORATION PROJECT-2009-2.1.1.1/241995</award-id>
</award-group>
<award-group id="funding-4">
<funding-source>‘Agence Nationale de la Recherche’</funding-source>
</award-group>
<award-group id="funding-5">
<funding-source>under the frame programme Investissements d'Avenir labelled</funding-source>
<award-id>ANR-10-IDEX-0002-02</award-id>
<award-id>ANR-10-LABX-0030-INRT</award-id>
<award-id>ANR-10-INBS-07 PHENOMIN</award-id>
</award-group>
<award-group id="funding-6">
<funding-source>National Institute of Health</funding-source>
<award-id>U01 AG029213-01A2</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>